On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Ex ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Net Loss: Net loss for the first quarter of 2025 was $6.8 million compared to a net loss of $2.9 million for the first quarter of 2024. The increase in net loss is attributable primarily to the ...

CCS has saved more than $10 million in taxpayer dollars through the use of PropheSee, its predictive analytics platform, ...

Glucotrack has announced the receipt of St Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval for ...

With projected growth to US$ 68.5 billion by 2030, the POC diagnostics market presents significant opportunities. Companies ...

While breastfeeding has many benefits for a mother and her baby, it has one major drawback: It's incredibly difficult to know ...

IntroductionGestational diabetes (GD) is a condition that occurs during pregnancy, where a woman without diabetes develops high blood sugar levels. The condition typically appears in the second or ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...